Elena Santagostino

11PUBLICATIONS
42CO-AUTHORS
Gene and molecular therapyRehabilitationInfant and child healthHaematologyNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 03, 2021
Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A.

Elena Santagostino, Shadan Lalezari, Mark T Reding

|Mar 20, 2021
Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors.

Victor Jiménez-Yuste, Günter Auerswald, Gary Benson

|Feb 04, 2021
Comparison of quality of life, and emotional and functional profiles in older people with and without severe haemophilia.

Silvia Riva, Emanuela Marchesini, Emily Oliovecchio

|Dec 05, 2020
Safety and efficacy of nonacog alfa for the treatment of haemophilia B in children younger than 6 years of age in a routine clinical care setting: the EUREKIX registry study.

Ri Liesner, Nadine G Andersson, Tony Frisk

|Oct 23, 2020
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company.

Charles R M Hay, Midori Shima, Michael Makris

|Aug 04, 2020
WFH Guidelines for the Management of Hemophilia, 3rd edition.

Alok Srivastava, Elena Santagostino, Alison Dougall

Pageof 2

Frequent Collaborators

2 joint publications

Gili Kenet

2 joint publications

Kathelijn Fischer

2 joint publications

Johannes Oldenburg

2 joint publications

Mark T Reding